Europe Infectious Respiratory Disease Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Infectious Respiratory Disease Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI anything about the infectious respiratory disease diagnostics market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Europe infectious respiratory disease diagnostics market highlights
- The Europe infectious respiratory disease diagnostics market generated a revenue of USD 3,109.4 million in 2024.
- The market is expected to grow at a CAGR of 3% from 2025 to 2033.
- In terms of segment, reagents was the largest revenue generating product in 2024.
- Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 3,109.4 million |
| Market revenue in 2033 | USD 4,020.2 million |
| Growth rate | 3% (CAGR from 2025 to 2033) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.3% of the global infectious respiratory disease diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,635.6 million by 2033.
Market growth in this region can be attributed to an increase in incidence of infectious diseases, technological advancements, and proactive government initiatives. The government entities play a pivotal role in creating awareness among the people about the potential benefits of early diagnosis of infectious diseases.
In 2017, a new regulation was issued regarding IVD & medical devices in European countries, which is likely to be updated by 2022. The new regulation is expected to offer a more sustainable and robust framework for compliance of diagnostic devices.
Europe became the focal point in the novel coronavirus infection in early March 2020, with the disease spreading rapidly across the region. The geriatric population is at a high risk of infections, and the European region comprises large geriatric population; over 90.4 million people of the region’s population is aged over 65 years.
No credit card required*
Publish Date: Jan 16, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
Europe Infectious Respiratory Disease Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Respiratory Disease Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 66.96% in 2024.
Horizon Databook has segmented the Europe infectious respiratory disease diagnostics market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
Market growth in this region can be attributed to an increase in incidence of infectious diseases, technological advancements, and proactive government initiatives. The government entities play a pivotal role in creating awareness among the people about the potential benefits of early diagnosis of infectious diseases.
In 2017, a new regulation was issued regarding IVD & medical devices in European countries, which is likely to be updated by 2022. The new regulation is expected to offer a more sustainable and robust framework for compliance of diagnostic devices.
Europe became the focal point in the novel coronavirus infection in early March 2020, with the disease spreading rapidly across the region. The geriatric population is at a high risk of infections, and the European region comprises large geriatric population; over 90.4 million people of the region’s population is aged over 65 years.
- Europe Infectious Respiratory Disease Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Reagents
- Services
- Europe Infectious Respiratory Disease Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Molecular Diagnostics
- Immunoassays
- Microbiology
- Rapid/Point-of-Care Diagnostics
- Other Technologies
- Europe Infectious Respiratory Disease Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
- COVID-19
- Influenza
- Tuberculosis
- Respiratory Syncytial Virus (RSV)
- Non-tuberculosis Mycobacterium Testing
- Bacterial Pneumonia Testing
- Other Respiratory Diseases
- Europe Infectious Respiratory Disease Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
Reasons to subscribe to Infectious Respiratory Disease Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Infectious Respiratory Disease Diagnostics Market Outlook databook
- Our clientele includes a mix of Infectious Respiratory Disease Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Infectious Respiratory Disease Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Infectious Respiratory Disease Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Infectious Respiratory Disease Diagnostics Market, 2021-2033 (US$M)
Europe Product - Infectious Respiratory Disease Diagnostics Market Statistics, 2024 - 2033 (US$M)
